When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SNSS - Sunesis Pharma plummets 45% after retreating vecabrutinib program
Viracta Therapeutics Inc Com
Sunesis Pharmaceuticals (NASDAQ:SNSS) slumps 45% premarket on the heels of the announcement that it will not advance its non-covalent BTK inhibitor vecabrutinib into the planned Phase 2 portion of the Phase 1b/2 trial in adults with relapsed/refractory chronic lymphocytic leukemia (CLL) and other B-cell malignancies.
More news on: Sunesis Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,